Revance Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (36)

View All

Latest Posts

About This Stock More About This Stock
18 Key Biopharma Catalysts To Keep An Eye On In Q3
Article By: Benzinga
Saturday, July 10, 2021 3:54 PM EDT
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the coming months.
In this article: ZGNX, XENE, AERI, RVNC, ZYNE, CLSD, RGNX, KALV, ACER, VRCA
Read
Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal
Article By: ChinaBio® Today
Saturday, May 1, 2021 12:51 PM EDT
CANbridge Pharma of Beijing acquired a global license to LogicBio’s adeno-associated virus sL65 in gene therapy candidates for Fabry and Pompe disease treatments. CANbridge will make a $10 million upfront payment for the two candidates.
In this article: JNJ, RVNC, MIRM, LEGN, IMAB
Read
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Article By: Benzinga
Sunday, November 29, 2020 4:14 PM EDT
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the Thanksgiving holiday. The week kickstarted with lukewarm news on the coronavirus vaccine front.
In this article: AZN, MRK, PFE, VNDA, MRNA, STRO, RVNC, IMV, BNTX, LQDA
Read
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
Article By: Benzinga
Saturday, November 28, 2020 3:50 PM EDT
The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency had in inspecting facilities where drugs are being manufactured.
In this article: SNY, ADMP, EIGR, ALNY, BCRX, VNDA, ALKS, SUPN, RVNC, LQDA
Read
Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Article By: Benzinga
Sunday, November 22, 2020 8:18 AM EDT
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a strong note, thanks to positive vaccine data reported by Moderna Inc.
In this article: LLY, MDT, PFE, SNY, RHHBY, CBPO, ARWR, MRNA, ENTA, RVNC, RYTM, TWST, BNTX, LQDA
Read
All Posts

Latest Tweets for $RVNC

No tweets yet!

PARTNER HEADLINES